Perception, knowledge, practices and training regarding the risk of exposure to antineoplastic drugs in three French compounding units.


Journal

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
ISSN: 1477-092X
Titre abrégé: J Oncol Pharm Pract
Pays: England
ID NLM: 9511372

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 30 11 2023
pubmed: 15 2 2023
entrez: 14 2 2023
Statut: ppublish

Résumé

Healthcare workers are exposed to hazardous drugs such as antineoplastic drugs, which have potential carcinogenic, mutagenic and teratogenic effects. Protective measures must be taken after appropriate staff training to handle antineoplastic drugs in a safe way. The objective was to assess perception, knowledge, practices and training regarding the risk of exposure of healthcare workers in three French compounding units. This descriptive study was based on a questionnaire made of 33 questions divided into five sections related to the handling of antineoplastic drugs: perception of the risks, knowledge of the risks, protection practices, specific training and general questions. Among the 39 participants, over half considered their overall risk of exposure to antineoplastic drugs not being very low. Inhalation was known to 69.2% of them as possible route of contamination. The breakroom was identified by 28.9% of them as a place of contamination. The procedure in case of accidental exposure to antineoplastic drugs was known by 69.2%, but only half could explain it. Only 38.5% said they changed their gloves every 30 min as recommended. Barely half said that they had been trained specifically for the handling of antineoplastic drugs during an initial training. Over half wished to be informed, trained and aware of the proper handling of antineoplastic drugs. Although some of these results are encouraging, specifically when compared to the other settings where antineoplastic drugs are handled, there is still room for improvement. Efforts to build an adapted and impactful training program must pursue. Study CONTACT, ref. 19-504.

Identifiants

pubmed: 36785934
doi: 10.1177/10781552231156520
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1893-1906

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Clémence Delafoy (C)

Department of Pharmacy, Centre Hospitalier Universitaire de Caen, Caen, France.
Aliments Bioprocédés Toxicologie Environnements, Normandie Univ, UNICAEN, UNIROUEN, ABTE, Centre de Lutte Contre le Cancer F. Baclesse, Caen, France.

Hubert Benoist (H)

Department of Pharmacy, Centre Hospitalier Universitaire de Caen, Caen, France.
Aliments Bioprocédés Toxicologie Environnements, Normandie Univ, UNICAEN, UNIROUEN, ABTE, Centre de Lutte Contre le Cancer F. Baclesse, Caen, France.

Michèle Vasseur (M)

ULR 7365-GRITA - Groupe de Recherche sur les Formes Injectables et les Technologies Associées, CHU Lille, University of Lille, Lille, France.
Institute of Pharmacy, Institut de Pharmacie, CHU Lille, Lille, France.

Cécile Breuil (C)

Department of Pharmacy, Centre Hospitalier Universitaire de Caen, Caen, France.

Fabienne Divanon (F)

Departement of Pharmacy, Comprehensive Cancer Centre F. Baclesse, Caen, France.

Pascal Odou (P)

ULR 7365-GRITA - Groupe de Recherche sur les Formes Injectables et les Technologies Associées, CHU Lille, University of Lille, Lille, France.
Institute of Pharmacy, Institut de Pharmacie, CHU Lille, Lille, France.

Nicolas Simon (N)

ULR 7365-GRITA - Groupe de Recherche sur les Formes Injectables et les Technologies Associées, CHU Lille, University of Lille, Lille, France.
Institute of Pharmacy, Institut de Pharmacie, CHU Lille, Lille, France.

Guillaume Saint-Lorant (G)

Department of Pharmacy, Centre Hospitalier Universitaire de Caen, Caen, France.
Aliments Bioprocédés Toxicologie Environnements, Normandie Univ, UNICAEN, UNIROUEN, ABTE, Centre de Lutte Contre le Cancer F. Baclesse, Caen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH